Assessment of different strategies for scalable production and proliferation of human myoblasts.

Min-Wen Jason ChuaEge Deniz YildirimJun-Hao Elwin TanYan-Jiang Benjamin ChuaSuet-Mei Crystal LowSuet Lee Shirley DingChun-Wei LiZongmin JiangBin Tean TehKang YuNg Shyh-Chang

Published in: Cell proliferation (2019)

Further efforts to optimize the chemically defined differentiation of hESC-monolayer-myoblasts would be the most promising strategy for the scalable generation of human myoblasts, for applications in MTT and high-throughput drug screening.

Keyphrases

endothelial cells
high throughput
induced pluripotent stem cells
pluripotent stem cells
emergency department
single cell
adverse drug
electronic health record